1. Home
  2. VYNE vs SPPL Comparison

VYNE vs SPPL Comparison

Compare VYNE & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • SPPL
  • Stock Information
  • Founded
  • VYNE 2003
  • SPPL 2016
  • Country
  • VYNE United States
  • SPPL Singapore
  • Employees
  • VYNE N/A
  • SPPL N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • SPPL
  • Sector
  • VYNE Health Care
  • SPPL
  • Exchange
  • VYNE Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • VYNE 9.6M
  • SPPL 9.8M
  • IPO Year
  • VYNE 2018
  • SPPL 2023
  • Fundamental
  • Price
  • VYNE $0.35
  • SPPL $5.93
  • Analyst Decision
  • VYNE Buy
  • SPPL
  • Analyst Count
  • VYNE 2
  • SPPL 0
  • Target Price
  • VYNE $8.00
  • SPPL N/A
  • AVG Volume (30 Days)
  • VYNE 3.1M
  • SPPL 9.6K
  • Earning Date
  • VYNE 11-10-2025
  • SPPL 01-01-0001
  • Dividend Yield
  • VYNE N/A
  • SPPL N/A
  • EPS Growth
  • VYNE N/A
  • SPPL N/A
  • EPS
  • VYNE N/A
  • SPPL N/A
  • Revenue
  • VYNE $476,000.00
  • SPPL $4,591,508.00
  • Revenue This Year
  • VYNE N/A
  • SPPL N/A
  • Revenue Next Year
  • VYNE N/A
  • SPPL N/A
  • P/E Ratio
  • VYNE N/A
  • SPPL N/A
  • Revenue Growth
  • VYNE N/A
  • SPPL 24.27
  • 52 Week Low
  • VYNE $0.28
  • SPPL $2.16
  • 52 Week High
  • VYNE $4.30
  • SPPL $16.80
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 45.50
  • SPPL 54.51
  • Support Level
  • VYNE $0.34
  • SPPL $5.40
  • Resistance Level
  • VYNE $0.38
  • SPPL $6.13
  • Average True Range (ATR)
  • VYNE 0.03
  • SPPL 0.35
  • MACD
  • VYNE 0.00
  • SPPL -0.07
  • Stochastic Oscillator
  • VYNE 21.78
  • SPPL 35.93

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: